FDA ANNOUNCES ADVISORY BOARD MEETINGS

The Neurological Devices Panel of the Medical Devices Advisory Committee will meet Oct. 31 to discuss and make recommendations on a premarket notification application for a depression disorder device and discuss study reports for two recently approved neurological device premarket approval applications.

FDA (http://www.fda.gov/OHRMS/DOCKETS/98fr/2006-4247-nm00001.pdf)

The FDA will hold a public meeting and vendor display Oct. 25 to discuss the issues associated with the development, implementation, and use of a unique device identification system and the use of various automatic identification technologies.

FDA (http://www.fda.gov/OHRMS/DOCKETS/98fr/06n-0292-nm00001.pdf)